Study of the therapeutic effect of 188Re labeled folate targeting albumin nanoparticle coupled with cis-Diamminedichloroplatinum Cisplatin on human ovarian cancer

Bio-Medical Materials and Engineering

Volumn 24, Issue 1, 2014, Pages 711-722

  Tang, Qiusha ^a   Chen, Daozhen ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b Wuxi Hospital for Maternal and Child Health Care   (China)

Author keywords

188Reovarian cancer; albumin magnetic nanoparticles; Cisplatin; combinated therapy; folic acid

Indexed keywords

188REOVARIAN CANCER; CIS-PLATIN; COMBINATED THERAPY; FOLIC ACIDS; MAGNETIC NANO-PARTICLES;

BIOMEDICAL ENGINEERING; BIOTECHNOLOGY; CHEMOTHERAPY; DISEASES; NANOPARTICLES; PLATINUM COMPOUNDS; RADIOTHERAPY; TUMORS;

HYPERTHERMIA THERAPY;

ALBUMIN; CISPLATIN; DRUG CARRIER; FOLIC ACID; MAGNETIC NANOPARTICLE; RHENIUM 188;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG TARGETING; FLOW CYTOMETRY; GENERATOR; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; ISOTOPE LABELING; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; THERAPY EFFECT;

188REOVARIAN CANCER; ALBUMIN MAGNETIC NANOPARTICLES; CISPLATIN; COMBINATED THERAPY; FOLIC ACID;

ALBUMINS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; COMBINED MODALITY THERAPY; DRUG CARRIERS; FEMALE; FOLIC ACID; HUMANS; HYPERTHERMIA, INDUCED; LIGANDS; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; RADIOISOTOPES; RHENIUM;

EID: 84891139931     PISSN: 09592989     EISSN: None     Source Type: Journal    
DOI: 10.3233/BME-130859     Document Type: Conference Paper

References (32)

1. Mcguire WP, Hoskins WJ, Brady MF,et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer[J]. N Engl J Med.1996;334 (1): 230-2344
2. Eveno C, Dagois S, Guillot E, et al. Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): New aspects and validated indications[J]. Bull Cancer. 2008;95(1):141-1455
3. McQuellon RP, Russell GB, Shen P, et al. Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin[J]. Ann Surg Oncol. 2008;15(1):125-133.
4. Gesson-Paute A, Ferron G, Thomas F, et al. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): An experimental study[J]. Ann Surg Oncol. 2008;15(1):339-3444
5. Armstrong DK, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J]. N Engl J Med.2006;354(1):34-433
6. Shen P, Levine EA, Hall J, et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosiss[J]. Arch Surg. 2003;138(1): 26-333
7. Pestieau SR, Marchettini P, Stuart OA, et al. Prevention of intraperitoneal adhesions by intraperitoneal lavage and intraperitoneal 5- fluorouracil: Experimental studies [J]. Int Surg. 2002 ;87 (3): 195-2000
8. Yoshida Y,Sasaki H ,Kurokawa T ,et al . Efficacy of intraperitoneal continuous hyperthermic chemotherapy as consolidation therapy in patients with advanced epithelial ovarian cancer:a long2termfollow2up. Oncol Rep.2005;13 (1) :121 -12511
9. Gori J ,Castano R ,Toziano M,et al . Intraperitoneal hyperthermic chemotherapy in ovarian cancer. Int J Gynecol Cancer. 2005;15 (2) :233-23911
10. Gilchrist R K, Medal R, Shorey W D, et al. Selective inductive heating of lymph nodes [J]. Annals of Oncology. 1957;146 (4): 596-6066
11. Anatoly A. Kuznetsov,Victor I. Filippov,Renat N. Alyautdin,et al.Application of magnetic liposomes for magnetically guided transport of muscle relaxants and anti-cancer photodynamic drugs [J],Journal of Magnetism and Magnetic Materials. 2001;225:95-1000
12. Jordan A, Scholz R, Wust P, et al. Magnetic fluid hyperthermia (MFH): Cancer treatment with magnetic fluid induced excitation of biocompatible superparamagnetic nanoparticles [J]. J Magn Magn Mater.1999; 201(1-3): 413-4199
13. Jordan A, Wust P, Scholz R, et al. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo [J]. Int J Hyperthermia.1997;13(6):587- 6055
14. Jordan A, Wust P, Scholz R, et al. Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro [J]. Int J Hyperthermia.1996;12(6): 705-7222
15. Pollert E,Knizek M,Marysko M, et al .New Tc-tuned magnetic nanoparticles for self-controlled hyperthermia[J].Journal of Magnetism and Magnetic Materials.2007;316:122-1255
16. Anatoly A,Kuznetsov G,Lenoriev A, et al .Local radiofrequency-induced hyperemia using CuNi nanoparticles with therapeutically suitable Curie temperature [J] Journal of Magnetism and Magnetic Materials.2007;316:122-1255
17. Yan Shiyan, Zhang Dongsheng, Gu Ning, et al. Therapeutic effect of Fe2O3 nanoparticles combined with magnetic fluid hyperthermia on the cultured human liver cancer cells and xenograft liver cancer[J]. Journal of Nanoscience and Nanotechnology. 2005;5:1-88
18. ZHANG Dongsheng,TANG Qiusha,WANG Ziyu, et al. Therapeutic effects of nano-magnetoliposomes containing As2O3 combined with magnetic fluid hyperthermia on xenograft cervical carcinoma,Chinese Journal of Physical Medicine and Rehabilitation.2006;26:102-1044
19. Brezovich IA, Lilly MB, Meredith RF, et al. Hyperthermia of pet animal tumours with self-regulating ferromagnetic thermoseeds [J]. Int J Hyperthermia.1990;6(1): 117-1300
20. Atsumi H,Jeyadevan B,Sato Y, et al.heating efficiency of magnetite particles exposed to AC magnetic field.2007,310:2841-28433
21. Ajay K,,Gupta M ,Gupta.Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications Biomaterials.2005;26:3995-40211
22. Cong Xiaoming, Zhang Dongsheng, Tang Qiusha, et al. Biocompatibility of Mn0.5Zn0.5Fe2O4 nanoparticles used in tumor hyperthermia Journal of Southeast University(Natural Science Edition).2007;37(3):476-4788
23. Qiu-Sha Tang,Dao-Zhen Chen,Wen-Qun Xue,et al. Preparation and biodistribution of 188Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles (188Re-folate-CDDP/HSA MNPs) in vivo,International Journal of Nanomedicine.2011;6:3077-30855
24. CHEN Daozhen, TANG Qiusha,LI Xiangdong, et al. The biocompatibility of Fe3O4 magnetic nanoparticles and their cytotoxic effect on MCF-7 cells. International Journal of Nanomedicine. 2012;7:4973-49788
25. CHEN Daozhen,TANG Qiusha,XUE Wenqun, et al. The preparation and characterization of folate-conjugated human serum albumin(HSA) magnetic cisplatin nanoparticles(Folate-CDDP/HSA MNP,Journal of Biomedical Research. 2010;24(1):352-3588
26. Westermann AM, Grosen EA, Katschinski DM, et al. A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer[J]. Eur J Cancer.2001;37(9):1111-1117.
27. Zhang P, Wang D, Zheng G.Reversal effect of hyperthemia on multidrug resistant phenomena[J].Hua Xi Kou Qiang Yi Xue Za Zhi. 2003;21(2):127-129.
28. Saga T, Sakahara H, Nakamoto Y, et al. Enhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermia[J]. Eur J Cancer,2001;37(11):1429-1434.
29. Zareifar S, Jafari H, Geramizadeh B,The evaluation of cisplatin effect on tubular function in children on chemotherapy [J].Pediatr Hematol Oncol. 2013;30(1):18-24.
30. Tsukasakin, Whitworth C, Rybak L, et al. Acute changes in cochlear potentials due to cisplatin [J]. Hear Res.2000;149 (1- 2):189-193.
31. Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor[J]. Adv Drug Deliv Rev.2000;41(2):147-162.
32. Chen D, Tang Q, Xue W, et al. The preparation and characterization of folate-conjugated human serum albumin magnetic cisplatin nanoparticles[J].J Biomed Res.2010;24(1):26-32.